DER Reference Model Version 1.0.0
ecqm.measure

CMS158v7 - Pregnant women that had HBsAg testing

Rationale:

Pregnant women that had HBsAg testing. The U.S. Preventive Services Task Force (USPSTF) found good evidence that universal prenatal screening for hepatitis B virus (HBV) infection using hepatitis B surface antigen (HBsAg) substantially reduces prenatal transmission of HBV and the subsequent development of chronic HBV infection (USPSTF 2009). The current practice of vaccinating all infants against HBV infection and post-exposure prophylaxis with hepatitis B immune globulin administered at birth to infants of HBV-infected mothers substantially reduces the risk for acquiring HBV infection.